Skip to Main Content

Paper Details

Emerging therapeutic strategies for unmet need in neovascular age-related macular degeneration.
J Transl Med
12
2023
Neovascular age-related macular degeneration, VEGF, VEGF ligand/receptor, VEGF-A, aflibercept, anti-VEGF, bevacizumab, blindness, brolucizumab, faricimab, nAMD, neovascular age-related macular degeneration, patients, ranibizumab, vascular endothelial growth factor, visual impairment
Author NameAffiliation
Levon M KhachigianUniversity of New South Wales
Gerald LiewWestmead Institute for Medical Research, University of Sydney
Kelvin Yi Chong TeoSingapore National Eye Centre and Singapore Eye Research Institute
Kelvin Yi Chong TeoDuke-NUS Graduate Medical School, National University of Singapore
Tien Yin WongSingapore National Eye Centre and Singapore Eye Research Institute
Tien Yin WongDuke-NUS Graduate Medical School, National University of Singapore
Tien Yin WongTsinghua University
Tien Yin WongSingapore National Eye Centre and Singapore Eye Research Institute
Tien Yin WongDuke-NUS Graduate Medical School, National University of Singapore
Tien Yin WongTsinghua University
  • 1 - 10

Datasets

Release 1.2